The genus Salmonella is a group of bacteria that causes human systemic disease (non-typhoid salmonellosis), and they are one of the leading causes of foodborne illness in the world. They are able to survive in different environments because of their complex physiology that allows them to use various nutrient sources. Salmonella is also able to adapt to environmental stresses and can overcome immune responses by using sophisticated virulence mechanisms.

Market Dynamics

All around the world, foodborne diseases are frequently caused by salmonella. The demand for Salmonella testing is being driven by the increase in Salmonella outbreaks, which is causing public health concerns. In order to identify contaminated food products, launch necessary recalls, and stop the spread of illnesses further, quick and precise testing is essential.

It can be expensive for food companies to implement testing protocols for salmonella and to maintain testing facilities, especially for small and medium-sized businesses (SMEs). Initial costs for reagents, testing tools, and qualified employees might be high. The implementation of thorough Salmonella testing programs can be constrained by the continuing costs related to maintaining and updating testing systems and complying with regulatory regulations.

Key Features of the Study:

• This report provides an in-depth analysis of the global salmonella testing market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global salmonella testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific, Vitrosens Biotechnology, Merck KGaA, bioMérieux SA, Neogen Corporation, QIAGEN N.V., 3M, PerkinElmer Inc., Romer Labs Division Holding GmbH, Eurofins Scientific, Hardy Diagnostics, Charles River Laboratories, LabCorp, R-Biopharm AG, and Biomerica Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global salmonella testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global salmonella testing market

Detailed Segmentation:

• By Testing Method:
  • Culture-based Methods
  • Molecular-based Methods
  • Immunoassays
• By Sample Type:
  • Food
  • Water
  • Environmental Surfaces
• By Application:
  • Clinical Diagnostics
  • Food Safety Testing
  • Veterinary Diagnostics
• By End User:
  • Food Producers and Manufacturers
  • Contract Testing Laboratories
  • Government and Regulatory Bodies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• By Company:
  • Thermo Fisher Scientific
  • Vitrosens Biotechnology
  • Merck KGaA
  • bioMérieux SA
  • Neogen Corporation
  • QIAGEN N.V.
  • 3M
  • PerkinElmer Inc.
  • Romer Labs Division Holding GmbH
  • Eurofins Scientific
  • Hardy Diagnostics
  • Charles River Laboratories
  • LabCorp
  • R-Biopharm AG
  • Biomerica, Inc.